Medically reviewed by Dr. Tom Biernacki, DPM
Board-certified podiatric surgeon | Balance Foot & Ankle, Howell & Bloomfield Township, MI
Last reviewed: May 2026
The most important clinical decision with Longitudinal Erythronychia: Red Nail Lines Explained isn’t which treatment to choose — it’s identifying which subtype you have first. Our podiatrists see patients treated for the wrong subtype for months before the correct diagnosis leads to full resolution. Call (810) 206-1402 — expert podiatric care across Michigan.
Longitudinal erythronychia is a red or pink longitudinal band in the nail plate, running from the proximal nail fold to the free edge. It signals focal disruption of the nail matrix or nail bed — causes range from benign onychopapilloma to glomus tumor to Bowen disease (squamous cell carcinoma in situ). A systematic approach determines when observation is safe versus when biopsy is mandatory.
Causes by Frequency and Clinical Risk
| Cause | Frequency | Associated Features | Biopsy Required? |
|---|---|---|---|
| Onychopapilloma | Most common single cause | Subungual keratosis at free edge; distal fissuring; benign | Yes if diagnosis uncertain or growing |
| Glomus tumor | Common in subungual location | Triad: cold sensitivity, pinpoint tenderness, pain; MRI shows lesion | Yes — excision is both diagnostic and curative |
| Bowen disease (SCC in situ) | Important to exclude | Irregular band; nail dystrophy; may involve multiple nails | Yes — always biopsy atypical or expanding bands |
| Darier disease | Hereditary; multiple nails | Multiple red and white bands; V-shaped notching; AD inheritance | Clinical diagnosis; skin biopsy if uncertain |
| Inflammatory (LP, psoriasis) | Variable | Multiple nails; other skin/nail findings present | Usually not required; treat underlying condition |
Biopsy Decision Guide
| Feature | Low-Risk (observe) | High-Risk (biopsy) |
|---|---|---|
| Number of nails involved | Multiple nails | Single nail |
| Band width | Narrow, stable | Wide or widening |
| Nail dystrophy | Absent | Present (thickening, splitting) |
| Patient age | Young; multiple nails | Over 50; single nail |
| Subungual mass | None | Palpable mass; MRI lesion |
| History | Stable for years; known Darier/LP | New, growing, or unexplained |
Nail matrix biopsy for longitudinal erythronychia requires precise technique — a lateral longitudinal or punch biopsy targeting the lesion apex in the matrix. Nail unit surgery is performed in an anesthetized, bloodless field using a digital block and tourniquet. Permanent histology is sent; nail matrix biopsy scars can affect the nail plate permanently if performed incorrectly.
At Balance Foot & Ankle in Howell and Bloomfield Township, we evaluate nail unit lesions including longitudinal erythronychia and perform nail matrix biopsies when indicated. Call (810) 206-1402.
American Academy of Dermatology: Nail Conditions
Ready to Get Relief?
Same-day appointments available in Howell & Bloomfield Township, MI
4.9★ | 1,123 Reviews | 3,000+ Surgeries
Or call: (810) 206-1402
Doctor Answer
What is longitudinal erythronychia and what does it indicate?
Longitudinal erythronychia is a red streak running the length of the toenail, caused by a vascular or neoplastic lesion in the nail matrix or bed. While it can be benign — such as from a glomus tumor or inflammatory nail condition — it should always be evaluated because subungual amelanotic melanoma and squamous cell carcinoma can present this way. I recommend nail biopsy for solitary unexplained longitudinal erythronychia that persists or is associated with nail destruction.
Dr. Tom Biernacki, DPM is a board-certified foot & ankle surgeon (ABFAS & ABPM) at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has made him one of the most-followed foot & ankle educators on YouTube.